SMAIO SA (ALSMA) - Net Assets
Based on the latest financial reports, SMAIO SA (ALSMA) has net assets worth €6.01 Million EUR (≈ $7.03 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€14.11 Million ≈ $16.50 Million USD) and total liabilities (€8.10 Million ≈ $9.47 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ALSMA asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €6.01 Million |
| % of Total Assets | 42.59% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 51.26 |
SMAIO SA - Net Assets Trend (2018–2025)
This chart illustrates how SMAIO SA's net assets have evolved over time, based on quarterly financial data. Also explore SMAIO SA total assets for the complete picture of this company's asset base.
Annual Net Assets for SMAIO SA (2018–2025)
The table below shows the annual net assets of SMAIO SA from 2018 to 2025. For live valuation and market cap data, see SMAIO SA stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | €6.01 Million ≈ $7.03 Million |
-12.25% |
| 2024-12-31 | €6.85 Million ≈ $8.01 Million |
-36.62% |
| 2023-12-31 | €10.80 Million ≈ $12.63 Million |
+10.86% |
| 2022-12-31 | €9.75 Million ≈ $11.39 Million |
+1674.73% |
| 2021-12-31 | €-618.89K ≈ $-723.55K |
-41.34% |
| 2020-12-31 | €-437.87K ≈ $-511.92K |
-124.51% |
| 2019-12-31 | €1.79 Million ≈ $2.09 Million |
+440.49% |
| 2018-12-31 | €-524.71K ≈ $-613.44K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to SMAIO SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 164405700.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €8.24 Million | 137.09% |
| Total Equity | €6.01 Million | 100.00% |
SMAIO SA Competitors by Market Cap
The table below lists competitors of SMAIO SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
SolTech Energy Sweden AB
ST:SOLT
|
$49.11 Million |
|
PEDEVCO Corp
NYSE MKT:PED
|
$49.12 Million |
|
Tritax Big Box REIT plc
LSE:BBOX
|
$49.12 Million |
|
Roscan Gold Corp
V:ROS
|
$49.17 Million |
|
Kriti Nutrients Limited
NSE:KRITINUT
|
$49.09 Million |
|
Shareholder Value Beteiligungen AG
XETRA:SVE
|
$49.08 Million |
|
Australian Vanadium Ltd
AU:AVL
|
$49.07 Million |
|
Analabs Resources Bhd
KLSE:7083
|
$49.07 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SMAIO SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 6,847,938 to 6,009,334, a change of -838,604 (-12.2%).
- Net loss of 2,228,767 reduced equity.
- New share issuances of 1,904,657 increased equity.
- Other factors decreased equity by 514,494.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-2.23 Million | -37.09% |
| Share Issuances | €1.90 Million | +31.69% |
| Other Changes | €-514.49K | -8.56% |
| Total Change | €- | -12.25% |
Book Value vs Market Value Analysis
This analysis compares SMAIO SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 7.66x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2018-12-31 | €-0.10 | €8.16 | x |
| 2019-12-31 | €0.34 | €8.16 | x |
| 2020-12-31 | €-0.08 | €8.16 | x |
| 2021-12-31 | €-0.12 | €8.16 | x |
| 2022-12-31 | €1.87 | €8.16 | x |
| 2023-12-31 | €2.07 | €8.16 | x |
| 2024-12-31 | €1.31 | €8.16 | x |
| 2025-12-31 | €1.07 | €8.16 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SMAIO SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -37.09%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -24.33%
- • Asset Turnover: 0.65x
- • Equity Multiplier: 2.35x
- Recent ROE (-37.09%) is below the historical average (-17.61%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2018 | 0.00% | -339.43% | 0.06x | 0.00x | €-510.84K |
| 2019 | -94.52% | -432.84% | 0.10x | 2.15x | €-1.87 Million |
| 2020 | 0.00% | -180.48% | 0.19x | 0.00x | €-2.18 Million |
| 2021 | 0.00% | -145.39% | 0.26x | 0.00x | €-3.03 Million |
| 2022 | 29.20% | 116.54% | 0.20x | 1.23x | €1.87 Million |
| 2023 | -4.13% | -8.29% | 0.36x | 1.40x | €-1.53 Million |
| 2024 | -34.30% | -42.73% | 0.47x | 1.72x | €-3.03 Million |
| 2025 | -37.09% | -24.33% | 0.65x | 2.35x | €-2.83 Million |
Industry Comparison
This section compares SMAIO SA's net assets metrics with peer companies in the Health Information Services industry.
Industry Context
- Industry: Health Information Services
- Average net assets among peers: $60,932,586
- Average return on equity (ROE) among peers: -4.60%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SMAIO SA (ALSMA) | €6.01 Million | 0.00% | 1.35x | $49.11 Million |
| AbL Diagnostics SA (ABLD) | $7.49 Million | 3.81% | 0.58x | $38.59 Million |
| AMA Corp PLC (ALAMA) | $2.85 Million | 0.00% | 3.76x | $7.19 Million |
| Intrasense (ALINS) | $2.26 Million | -78.19% | 1.35x | $12.01 Million |
| Cegedim S.A. (CGM) | $111.29 Million | 14.41% | 1.68x | $145.99 Million |
| Equasens S. A. (EQS) | $240.69 Million | 15.04% | 0.65x | $549.40 Million |
| Media Lab SpA (MLLAB) | $1.02 Million | 17.35% | 0.63x | $7.58 Million |
About SMAIO SA
S.M.A.I.O S.A. provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery. It offers solutions for surgeons including programs for training, assistance with surgical planning based on a database called KEOPS. The company also offers solutions such as i-PLAN, take control of the realignment plan; i-PERFORM, take control of the surgical plan; i-CHE… Read more